Nexstim
Focussing on strategic prioritiesNexstim
Licensing discussions with academic centre endNexstim
Making an impression in depressionNexstim
Warrants to be topped up with share placementNexstim
Q319 update shows therapy business momentumNexstim
A possible new opportunity in severe depressionNexstim
Voluntary loan repayments remove Kreos uncertaintyNexstim
Promising progress with NBTNexstim
Getting back on the front footNexstim
Terms of the rights issue announced